Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #674104 on NorthWest Biotherapeutics Inc (NWBO)
sentiment_stocks
02/23/24 3:04 AM
#674124 RE: attilathehunt #674104
Let me give you an example in relation to personalized immunotherapies. Because the U.K.’s health ecosystem is joined up, we're able to bring clinicians and health care organization leaders into the regulatory discussions. In this way, we can consider dedicated regulatory pathways for products that have a very short shelf life or products that are tailored to the genomics of a particular cancer or indeed therapies for very rare genetic disorders. These are quite a challenge for regulation, and it's not going to be ‘one size fits all.’ The question is whether we can license platforms as opposed to products. This is a really exciting time in the evolution of regulation, and my ambition is for our voice to be part of that international discussion that is now ongoing.